L3VLUP
ProSign in

AORT in the 13F filings

Artivion Inc · CUSIP 228903100

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
31 Dec 2023
the date the book describes
Filed
8 Feb 2024
up to 45 days after the quarter end
Managers listing it
1
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q3 2023 and Q4 2023; 1 listed it in both
Shares listed
527,537
combined, among listed positions
Reported value
$9.4m
combined, at the quarter end

Among the 93 comparable managers: 1 buyer (opened or added shares) and 0 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +1,009.

Managers listing AORT in Q4 2023

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

1 of 1 holder

ActionFiling
First Eagle Investment Management LLC527,537$9.4munder 0.1%Added+1,0098 Feb 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2023 to Q4 2023, among managers that listed it in both quarters or opened it.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
1 in Q3 2024 to 1 in Q2 2026

Tracked managers listing it, at least.

011222014201720182019202020222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
AORT by quarter
QuarterHoldersReported valueBuyersSellers
Q4 20131$2.1mn.a.n.a.
Q1 20141$2.3mn.a.n.a.
Q3 20161$37mn.a.n.a.
Q4 20161$54mn.a.n.a.
Q1 20171$52mn.a.n.a.
Q2 20171$57mn.a.n.a.
Q3 20172$66mn.a.n.a.
Q4 20172$59mn.a.n.a.
Q1 20182$62mn.a.n.a.
Q2 20182$86mn.a.n.a.
Q3 20181$99mn.a.n.a.
Q4 20181$67mn.a.n.a.
Q1 20192$94mn.a.n.a.
Q2 20192$40mn.a.n.a.
Q3 20191$35mn.a.n.a.
Q4 20191$42mn.a.n.a.
Q1 20201$50mn.a.n.a.
Q2 20201$57mn.a.n.a.
Q3 20201$8.9mn.a.n.a.
Q2 20211$919kn.a.n.a.
Q3 20211$531kn.a.n.a.
Q4 20211$722kn.a.n.a.
Q1 20221$1.8mn.a.n.a.
Q2 20221$2.3mn.a.n.a.
Q3 20221$1.9mn.a.n.a.
Q4 20221$1.7mn.a.n.a.
Q1 20231$3.1mn.a.n.a.
Q2 20231$6.6mn.a.n.a.
Q3 20231$8.0mn.a.n.a.
Q4 20231$9.4m10
Q1 20241$12m10
Q2 20242$25m20
Q3 20241$17m10
Q4 20241$17m01
Q1 20251$11m01
Q2 20251$13m01
Q3 20251$14m01
Q4 20252$15m1114
Q1 20261$11m1211
Q2 20261$7.8m157

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

AORT and LLY →AORT and JNJ →AORT and VRTX →Choose a stock to compare with AORT →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own AORT, latest filings →Back to the 13F Explorer →